Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год

Применить Всего найдено 11. Отображено 11.
01-11-2012 дата публикации

Pharmaceutical composition, comprising an anti-CD6 monoclonal antibody used in the diagnosis and treatment of rheumatoid arthritis

Номер: AU2007336563B2
Принадлежит:

The present invention concerns immunology and in particular the preparation of pharmaceutical compositions which contain a humanized monoclonal antibody which recognizes the leukocyte differentiation antigen CD6. In accordance with the disclosure, the aim of this invention is to provide pharmaceutical compositions containing an anti-CD6 humanized monoclonal antibody for the diagnosis and treatment of autoimmune diseases in particular rheumatoid arthritis.

Подробнее
12-03-2013 дата публикации

PHARMACEUTICAL COMPOSITION, COMPRISING AN ANTI-CD6 MONOCLONAL ANTIBODY USED IN THE DIAGNOSIS AND TREATMENT OF RHEUMATOID ARTHRITIS

Номер: CA0002676185C

The present invention concerns immunology and in particular the preparation of pharmaceutical compositions which contain a humanized monoclonal antibody which recognizes the leukocyte differentiation antigen CD6. In accordance with the disclosure, the aim of this invention is to provide pharmaceutical compositions containing an anti-CD6 humanized monoclonal antibody for the diagnosis and treatment of autoimmune diseases in particular rheumatoid arthritis.

Подробнее
03-07-2008 дата публикации

PHARMACEUTICAL COMPOSITION, COMPRISING AN ANTI-CD6 MONOCLONAL ANTIBODY USED IN THE DIAGNOSIS AND TREATMENT OF RHEUMATOID ARTHRITIS

Номер: CA0002676185A1

The present invention concerns immunology and in particular the preparation of pharmaceutical compositions which contain a humanized monoclonal antibody which recognizes the leukocyte differentiation antigen CD6. In accordance with the disclosure, the aim of this invention is to provide pharmaceutical compositions containing an anti-CD6 humanized monoclonal antibody for the diagnosis and treatment of autoimmune diseases in particular rheumatoid arthritis.

Подробнее
01-12-2009 дата публикации

PHARMACEUTICAL COMPOSITION, COMPRISING AN ANTI-CD6 MONOCLONAL ANTIBODY USED IN THE DIAGNOSIS AND TREATMENT OF RHEUMATOID ARTHRITIS

Номер: KR1020090122910A
Принадлежит:

The present invention concerns immunology and in particular the preparation of pharmaceutical compositions which contain a humanized monoclonal antibody which recognizes the leukocyte differentiation antigen CD6. In accordance with the disclosure, the aim of this invention is to provide pharmaceutical compositions containing an anti-CD6 humanized monoclonal antibody for the diagnosis and treatment of autoimmune diseases in particular rheumatoid arthritis. COPYRIGHT KIPO & WIPO 2010 ...

Подробнее
09-03-2017 дата публикации

PHARMACEUTICAL COMPOSITION COMPRISING AN ANTI-CD6 MONOCLONAL ANTIBODY USED IN THE DIAGNOSIS AND TREATMENT OF RHEUMATOID ARTHRITIS

Номер: US20170066835A1
Принадлежит:

The present invention is related to the branch of immunology and particularly with the generation of pharmaceutical compositions containing a humanized monoclonal antibody recognizing the leukocyte differentiation antigen CD6. Accordingly with that statement, the purpose of this invention is to provide pharmaceutical compositions which contain a humanized anti-monoclonal antibody for the diagnosis and treatment of Autoimmune Diseases, particularly the Rheumatoid Arthritis. 1. A composition comprising an antiCD6 monoclonal antibody that recognizes human leukocyte differentiation antigen CD6 and does not inhibit the binding of CD6 to ALCAM , wherein the antiCD6 monoclonal antibody is T1h and produced by secreting hybridoma IOR-T1A deposited with the ECACC as deposit No. ECACC 96112640 , and wherein the antiCD6 monoclonal antibody is in a therapeutic amount to cause at least 60% depletion of CD6+ lymphocytes within about 7 weeks in a subj ect.2. The composition of further comprising a pharmaceutical carrier.3. The composition of claim 1 , further comprising an anti-inflammatory agent. This application is a continuation application of copending U.S. patent application Ser. No. 14/252,002, filed on Apr. 14, 2014, which in turn is a divisional application of copending U.S. patent application Ser. No. 12/525,442 filed on Dec. 9, 2009 and claiming priority thereto which in turn is an application filed under 35 U.S.C. §371 claiming priority of International Patent Application No. PCT/CU2007/000021 filed on Dec. 24, 2007, which in turn claims priority of Cuban Application No. 2006-0250 filed on Dec. 26, 2006, the contents of which are incorporated by reference herein for all purposes.The present invention is related to the human medicine and especially with the generation of pharmaceutical compositions comprising a humanized monoclonal antibody recognizing the leukocyte differentiation antigen CD6, and particularly with therapeutic formulations which contain a humanized ...

Подробнее
15-04-2010 дата публикации

PHARMACEUTICAL COMPOSITION COMPRISING AN ANTI-CD6 MONOCLONAL ANTIBODY USED IN THE DIAGNOSIS AND TREATMENT OF RHEUMATOID ARTHRITIS

Номер: US20100092423A1
Принадлежит: CENTRO DE INMUNOLGÍA MOLECULAR

The present invention is related to the branch of immunology and particularly with the generation of pharmaceutical compositions containing a humanized monoclonal antibody recognizing the leukocyte differentiation antigen CD6. Accordingly with that statement, the purpose of this invention is to provide pharmaceutical compositions which contain a humanized anti-CD6 monoclonal antibody for the diagnosis and treatment of Autoimmune Diseases, particularly the Rheumatoid Arthritis.

Подробнее
24-02-2010 дата публикации

Pharmaceutical composition, comprising an anti-CD6 monoclonal antibody used in the diagnosis and treatment of rheumatoid arthritis

Номер: CN0101657215A
Принадлежит:

The present invention concerns immunology and in particular the preparation of pharmaceutical compositions which contain a humanized monoclonal antibody which recognizes the leukocyte differentiationantigen CD6. In accordance with the disclosure, the aim of this invention is to provide pharmaceutical compositions containing an anti-CD6 humanized monoclonal antibody for the diagnosis and treatmentof autoimmune diseases in particular rheumatoid arthritis.

Подробнее
08-04-2009 дата публикации

PHARMACEUTICAL COMPOSITION THAT INCLUDES A MONOCLONAL ANTIBODY ANTI CD6 USED IN THE DIAGNOSIS AND TREATMENT OF ARTIRITIS REUMATOIDE

Номер: AR0000064527A1
Принадлежит:

Composiciones farmacéuticas que contienen un Anticuerpo Monoclonal humanizado que reconoce el antígeno de diferenciacion leucocitario CD6. De acuerdo con lo expuesto, el objeto de esta invencion es proporcionar composiciones farmacéuticas que contengan un Anticuerpo Monoclonal humanizado anti CD6 para el diagnostico y tratamiento de enfermedades autoinmunes en particular la Artritis Reumatoide. Reivindicacion 2: La composicion farmacéutica segun reivindicacion 1 caracterizada porque el anticuerpo monoclonal anti-CD6 es el anticuerpo humanizado T1h producido por el hibridoma IOR-T1A con No. de deposito ECACC 96112640. Reivindicacion 3: La composicion farmacéutica segun reivindicacion 1 caracterizada porque comprende el anticuerpo humanizado T1h solo o en combinacion con uno de los agentes seleccionados del grupo de: Un agente quimioterapéuticos, Un anticuerpos monoclonales específicos contra moléculas de superficie de linfocitos T y B, Una citosina. Reivindicacion 4: La composicion farmacéutica ...

Подробнее
28-01-2016 дата публикации

Pharmaceutical composition comprising an anti-cd6 monoclonal antibody used in the diagnosis and treatment of rheumatoid arthritis

Номер: US20160024220A1
Принадлежит: Centro de Immunologia Molecular

The present invention is related to the branch of immunology and particularly with the generation of pharmaceutical compositions containing a humanized monoclonal antibody recognizing the leukocyte differentiation antigen CD6. Accordingly with that statement, the purpose of this invention is to provide pharmaceutical compositions which contain a humanized anti-CD6 monoclonal antibody for the diagnosis and treatment of Autoimmune Diseases, particularly the Rheumatoid Arthritis.

Подробнее
18-11-2009 дата публикации

Pharmaceutical composition, comprising an anti-cd6 monoclonal antibody used in the diagnosis and treatment of rheumatoid arthritis

Номер: EP2119452A1
Принадлежит: Centro de Immunologia Molecular

The present invention is related to the branch of immunology and particularly with the generation of pharmaceutical compositions containing a humanized monoclonal antibody recognizing the leukocyte differentiation antigen CD6. Accordingly with that statement, the purpose of this invention is to provide pharmaceutical compositions which contain a humanized anti-CD6 monoclonal antibody for the diagnosis and treatment of Autoimmune Diseases, particularly the Rheumatoid Arthritis.

Подробнее
10-12-2008 дата публикации

PHARMACEUTICAL COMPOSITION INCLUDING AN ANTI CD6 MONOCLONAL ANTIBODY USED IN THE DIAGNOSIS AND TREATMENT OF RHEUMATOID ARTHRITIS

Номер: PE20081553A1
Принадлежит: Centro Inmunologia Molecular

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE UN ANTICUERPO MONOCLONAL ANTI-CD6 T1h PRODUCIDO POR EL HIBRIDOMA IOR-T1A. ADICIONALMENTE PUEDE CONTENER UN AGENTE QUIMIOTERAPEUTICO TAL COMO METROTEXATO, ANTICUERPO MONOCLONAL ANTI CD-20, FACTOR DE NECROSIS TUMORAL ALFA. DICHA COMPOSICION ES UTIL EN EL TRATAMIENTO DE ARTRITIS REUMATOIDE REFERS TO A PHARMACEUTICAL COMPOSITION INCLUDING AN ANTI-CD6 T1h MONOCLONAL ANTIBODY PRODUCED BY THE IOR-T1A HYBRIDOMA. ADDITIONALLY IT MAY CONTAIN A CHEMOTHERAPY AGENT SUCH AS METROTEXATE, ANTI CD-20 MONOCLONAL ANTIBODY, ALPHA TUMOR NECROSIS FACTOR. SUCH COMPOSITION IS USEFUL IN THE TREATMENT OF RHEUMATOID ARTHRITIS

Подробнее